This is a preview of subscription content, log in via an institution to check access.
Reference
Federal Trade Commission. FTC Study: In FY 2012, Branded Drug Firms Significantly Increased the Use of Potential Pay-for-Delay Settlements to Keep Generic Competitors off the Market. Media Release : 17 Jan 2013. Available from: URL: http://www.ftc.gov
Rights and permissions
About this article
Cite this article
Rise in pay-for-delay deals. PharmacoEcon Outcomes News 670, 11 (2013). https://doi.org/10.1007/s40274-013-0114-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0114-2